An Integrated Approach to Testing and Assessment to Support Grouping and Read-Across of Nanomaterials After Inhalation Exposure

Introduction: Here, we describe the generation of hypotheses for grouping nanoforms (NFs) after inhalation exposure and the tailored Integrated Approaches to Testing and Assessment (IATA) with which each specific hypothesis can be tested. This is part of a state-of-the-art framework to support the hypothesis-driven grouping and read-across of NFs, as developed by the EU-funded Horizon 2020 project GRACIOUS. Development of Grouping Hypotheses and IATA: Respirable NFs, depending on their physicochemical properties, may dissolve either in lung lining fluid or in acidic lysosomal fluid after uptake by cells. Alternatively, NFs may also persist in particulate form. Dissolution in the lung is, therefore, a decisive factor for the toxicokinetics of NFs. This has led to the development of four hypotheses, broadly grouping NFs as instantaneous, quickly, gradually, and very slowly dissolving NFs. For instantaneously dissolving NFs, hazard information can be derived by read-across from the ions. For quickly dissolving particles, as accumulation of particles is not expected, ion toxicity will drive the toxic profile. However, the particle aspect influences the location of the ion release. For gradually dissolving and very slowly dissolving NFs, particle-driven toxicity is of concern. These NFs may be grouped by their reactivity and inflammation potency. The hypotheses are substantiated by a tailored IATA, which describes the minimum information and laboratory assessments of NFs under investigation required to justify grouping. Conclusion: The GRACIOUS hypotheses and tailored IATA for respiratory toxicity of inhaled NFs can be used to support decision making regarding Safe(r)-by-Design product development or adoption of precautionary measures to mitigate potential risks. It can also be used to support read-across of adverse effects such as pulmonary inflammation and subsequent downstream effects such as lung fibrosis and lung tumor formation after long-term exposure.

[1]  Peter Laux,et al.  Organ burden of inhaled nanoceria in a 2-year low-dose exposure study: dump or depot? , 2020, Nanotoxicology.

[2]  Heinrich Ernst,et al.  Effects from a 90-day inhalation toxicity study with cerium oxide and barium sulfate nanoparticles in rats , 2017, Particle and Fibre Toxicology.

[3]  N. Zíková,et al.  Markers of lipid oxidative damage in the exhaled breath condensate of nano TiO2 production workers , 2017, Nanotoxicology.

[4]  Mark Bradley,et al.  Differential pro-inflammatory effects of metal oxide nanoparticles and their soluble ions in vitro and in vivo; zinc and copper nanoparticles, but not their ions, recruit eosinophils to the lungs , 2012, Nanotoxicology.

[5]  Ian Mudway,et al.  Evaluating the Toxicity of Airborne Particulate Matter and Nanoparticles by Measuring Oxidative Stress Potential—A Workshop Report and Consensus Statement , 2008, Inhalation toxicology.

[6]  E. Latz,et al.  New insights into mechanisms controlling the NLRP3 inflammasome and its role in lung disease. , 2014, The American journal of pathology.

[7]  Robert N Grass,et al.  Exposure of engineered nanoparticles to human lung epithelial cells: influence of chemical composition and catalytic activity on oxidative stress. , 2007, Environmental science & technology.

[8]  Subchronic.  Subchronic Inhalation Toxicity: 90-Day Study (OECD TG 413) , 2018, OECD Series on Testing and Assessment.

[9]  Antonio Marcomini,et al.  Grouping and Read-Across Approaches for Risk Assessment of Nanomaterials , 2015, International journal of environmental research and public health.

[10]  V J Feron,et al.  Subchronic inhalation toxicity of amorphous silicas and quartz dust in rats. , 1991, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[11]  Tian Xia,et al.  The role of oxidative stress in ambient particulate matter-induced lung diseases and its implications in the toxicity of engineered nanoparticles. , 2008, Free radical biology & medicine.

[12]  Reinhard Kreiling,et al.  Case studies putting the decision-making framework for the grouping and testing of nanomaterials (DF4nanoGrouping) into practice. , 2016, Regulatory toxicology and pharmacology : RTP.

[13]  Jia Liu,et al.  Contribution of oxidative stress to TiO2 nanoparticle-induced toxicity. , 2016, Environmental toxicology and pharmacology.

[14]  Z. Fu,et al.  Titanium dioxide nanoparticle stimulating pro‐inflammatory responses in vitro and in vivo for inhibited cancer metastasis , 2018, Life sciences.

[15]  Test No. 412: Subacute Inhalation Toxicity: 28-Day Study , 2018, OECD Guidelines for the Testing of Chemicals, Section 4.

[16]  N. Jacobsen,et al.  Role of oxidative damage in toxicity of particulates , 2010, Free radical research.

[17]  Penny Nymark,et al.  Adverse outcome pathways as a tool for the design of testing strategies to support the safety assessment of emerging advanced materials at the nanoscale , 2020, Particle and Fibre Toxicology.

[18]  U. Mohr,et al.  Neoplastic lung lesions in rat after chronic exposure to crystalline silica. , 1995, Scandinavian journal of work, environment & health.

[19]  Robert Landsiedel,et al.  In Vitro and In Vivo Short-Term Pulmonary Toxicity of Differently Sized Colloidal Amorphous SiO2 , 2018, Nanomaterials.

[20]  David M. Brown,et al.  Neutrophil activation by nanomaterials in vitro: comparing strengths and limitations of primary human cells with those of an immortalized (HL-60) cell line , 2020, Nanotoxicology.

[21]  M. Sayan,et al.  The NLRP3 inflammasome in pathogenic particle and fibre-associated lung inflammation and diseases , 2015, Particle and Fibre Toxicology.

[22]  P. Lin,et al.  Particulate nature of inhaled zinc oxide nanoparticles determines systemic effects and mechanisms of pulmonary inflammation in mice , 2015, Nanotoxicology.

[23]  Flemming R. Cassee,et al.  Pulmonary toxicity in rats following inhalation exposure to poorly soluble particles: The issue of impaired clearance and the relevance for human health hazard and risk assessment. , 2019, Regulatory toxicology and pharmacology : RTP.

[24]  Rogene F. Henderson,et al.  Concepts In Inhalation Toxicology , 1995 .

[25]  Wolfgang Koch,et al.  Chronic Inhalation Exposure of Wistar Rats and two Different Strains of Mice to Diesel Engine Exhaust, Carbon Black, and Titanium Dioxide , 1995 .

[26]  Roel P F Schins,et al.  Inhaled particles and lung cancer. Part A: Mechanisms , 2004, International journal of cancer.

[27]  Antonio Marcomini,et al.  In vitro assessment of engineered nanomaterials using a hepatocyte cell line: cytotoxicity, pro-inflammatory cytokines and functional markers , 2012, Nanotoxicology.

[28]  Reinhard Kreiling,et al.  A decision-making framework for the grouping and testing of nanomaterials (DF4nanoGrouping). , 2015, Regulatory toxicology and pharmacology : RTP.

[29]  F. Cassee,et al.  Mechanism of Action of TiO2: Recommendations to Reduce Uncertainties Related to Carcinogenic Potential. , 2020, Annual review of pharmacology and toxicology.

[30]  K. Savolainen,et al.  The effect of fiber length on the dissolution by macrophages of rockwool and glasswool fibers. , 1995, Environmental research.

[31]  B. van Ravenzwaay,et al.  Time course of lung retention and toxicity of inhaled particles: short-term exposure to nano-Ceria , 2014, Archives of Toxicology.

[32]  Tao Chen,et al.  Genotoxicity Assessment of Nanomaterials: Recommendations on Best Practices, Assays, and Methods , 2018, Toxicological sciences : an official journal of the Society of Toxicology.

[33]  F. Cassee,et al.  Optimization of an air-liquid interface in vitro cell co-culture model to estimate the hazard of aerosol exposures , 2020, Journal of aerosol science.

[34]  Nina Jeliazkova,et al.  A framework for grouping and read-across of nanomaterials- supporting innovation and risk assessment , 2020, Nano Today.

[35]  Alexandra Kroll,et al.  Testing Metal‐Oxide Nanomaterials for Human Safety , 2010, Advanced materials.

[36]  R. Pieters,et al.  Representing the Process of Inflammation as Key Events in Adverse Outcome Pathways. , 2018, Toxicological sciences : an official journal of the Society of Toxicology.

[37]  James S. Brown,et al.  Dosimetric Comparisons of Particle Deposition and Retention in Rats and Humans , 2005, Inhalation toxicology.

[38]  B. Rothen‐Rutishauser,et al.  Multicellular Human Alveolar Model Composed of Epithelial Cells and Primary Immune Cells for Hazard Assessment. , 2020, Journal of visualized experiments : JoVE.

[39]  Flemming R Cassee,et al.  Comparative hazard identification of nano- and micro-sized cerium oxide particles based on 28-day inhalation studies in rats , 2014, Nanotoxicology.

[40]  J. Everitt,et al.  Pulmonary responses of mice, rats, and hamsters to subchronic inhalation of ultrafine titanium dioxide particles. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.

[41]  M. Niehof,et al.  Cerium oxide and barium sulfate nanoparticle inhalation affects gene expression in alveolar epithelial cells type II , 2018, Journal of Nanobiotechnology.

[42]  Agnes G Oomen,et al.  Tissue distribution of inhaled micro- and nano-sized cerium oxide particles in rats: results from a 28-day exposure study. , 2012, Toxicological sciences : an official journal of the Society of Toxicology.

[43]  Craig A. Poland,et al.  Zeta potential and solubility to toxic ions as mechanisms of lung inflammation caused by metal/metal oxide nanoparticles. , 2012, Toxicological sciences : an official journal of the Society of Toxicology.

[44]  Benoit Nemery,et al.  Cytokine production by co-cultures exposed to monodisperse amorphous silica nanoparticles: the role of size and surface area. , 2012, Toxicology letters.

[45]  Vicki Stone,et al.  An in vitro liver model - assessing oxidative stress and genotoxicity following exposure of hepatocytes to a panel of engineered nanomaterials , 2012, Particle and Fibre Toxicology.

[46]  Hedwig M Braakhuis,et al.  Physicochemical characteristics of nanomaterials that affect pulmonary inflammation , 2014, Particle and Fibre Toxicology.

[47]  Hedwig M Braakhuis,et al.  Simple in vitro models can predict pulmonary toxicity of silver nanoparticles , 2016, Nanotoxicology.

[48]  Robert Landsiedel,et al.  Applicability of rat precision-cut lung slices in evaluating nanomaterial cytotoxicity, apoptosis, oxidative stress, and inflammation. , 2014, Toxicology and applied pharmacology.

[49]  W. D. de Jong,et al.  Novel insights into the risk assessment of the nanomaterial synthetic amorphous silica, additive E551, in food , 2015, Nanotoxicology.

[50]  E. Niki,et al.  Comparison of acute oxidative stress on rat lung induced by nano and fine-scale, soluble and insoluble metal oxide particles: NiO and TiO2 , 2012, Inhalation toxicology.

[51]  M. Birrell,et al.  The role of the NLRP3 inflammasome in the pathogenesis of airway disease. , 2011, Pharmacology & therapeutics.

[52]  Appendix R.6-1 for nanoforms applicable to the Guidance on QSARs and Grouping of Chemicals , 2019 .

[53]  W. D. de Jong,et al.  Identification of the appropriate dose metric for pulmonary inflammation of silver nanoparticles in an inhalation toxicity study , 2015, Nanotoxicology.

[54]  F. Cassee,et al.  An Air-liquid Interface Bronchial Epithelial Model for Realistic, Repeated Inhalation Exposure to Airborne Particles for Toxicity Testing. , 2020, Journal of visualized experiments : JoVE.

[55]  A. L. Le Faou,et al.  Macrophage Culture as a Suitable Paradigm for Evaluation of Synthetic Vitreous Fibers , 2008 .

[56]  David M. Brown,et al.  Proinflammogenic Effects of Low-Toxicity and Metal Nanoparticles In Vivo and In Vitro: Highlighting the Role of Particle Surface Area and Surface Reactivity , 2007, Inhalation toxicology.

[57]  J. Martens,et al.  Oxidative stress and proinflammatory effects of carbon black and titanium dioxide nanoparticles: role of particle surface area and internalized amount. , 2009, Toxicology.

[58]  R. Altenburger,et al.  Environmental mixtures of nanomaterials and chemicals: The Trojan-horse phenomenon and its relevance for ecotoxicity. , 2018, The Science of the total environment.

[59]  Gibson Peter,et al.  Cerium Dioxide, NM-211, NM-212, NM-213. Characterisation and test item preparation , 2014 .

[60]  J. Ather,et al.  Inflammasome Activity in Non-Microbial Lung Inflammation. , 2014, Journal of environmental immunology and toxicology.

[61]  Nicklas Raun Jacobsen,et al.  Comparative Hazard Identification by a Single Dose Lung Exposure of Zinc Oxide and Silver Nanomaterials in Mice , 2015, PloS one.

[62]  Hongtao Yu,et al.  Mechanisms of nanotoxicity: Generation of reactive oxygen species , 2014, Journal of food and drug analysis.

[63]  K. Driscoll.  TNFalpha and MIP-2: role in particle-induced inflammation and regulation by oxidative stress. , 2000, Toxicology letters.

[64]  C. Egles,et al.  Air-liquid interface exposure to aerosols of poorly soluble nanomaterials induces different biological activation levels compared to exposure to suspensions , 2016, Particle and Fibre Toxicology.

[65]  Andrea Haase,et al.  Nanomaterial grouping: Existing approaches and future recommendations , 2019, NanoImpact.

[66]  U. Vogel,et al.  Acute phase response and inflammation following pulmonary exposure to low doses of zinc oxide nanoparticles in mice , 2019, Nanotoxicology.

[67]  I. Hsiao,et al.  Trojan-horse mechanism in the cellular uptake of silver nanoparticles verified by direct intra- and extracellular silver speciation analysis. , 2015, Environmental science & technology.

[68]  H. Izumi,et al.  Significance of Intratracheal Instillation Tests for the Screening of Pulmonary Toxicity of Nanomaterials. , 2017, Journal of UOEH.

[69]  Bryan Hellack,et al.  Nanomaterial categorization by surface reactivity: A case study comparing 35 materials with four different test methods , 2020 .

[70]  W. Peijnenburg,et al.  Understanding Dissolution Rates via Continuous Flow Systems with Physiologically Relevant Metal Ion Saturation in Lysosome , 2020, Nanomaterials.

[71]  R. Hurt,et al.  Chemical Dissolution Pathways of MoS2 Nanosheets in Biological and Environmental Media. , 2016, Environmental science & technology.

[72]  M. Wiemann,et al.  Application of short-term inhalation studies to assess the inhalation toxicity of nanomaterials , 2014, Particle and Fibre Toxicology.

[73]  Thomas A. J. Kuhlbusch,et al.  In vivo effects: Methodologies and biokinetics of inhaled nanomaterials , 2018 .

[74]  Lang Tran,et al.  Comprehensive In Vitro Toxicity Testing of a Panel of Representative Oxide Nanomaterials: First Steps towards an Intelligent Testing Strategy , 2015, PloS one.

[75]  Monika Herrchen,et al.  The nanoGRAVUR framework to group (nano)materials for their occupational, consumer, environmental risks based on a harmonized set of material properties, applied to 34 case studies. , 2019, Nanoscale.

[76]  R. Bevan,et al.  Toxicity testing of poorly soluble particles, lung overload and lung cancer , 2018, Regulatory toxicology and pharmacology : RTP.

[77]  H. Sies,et al.  Oxidative stress: a concept in redox biology and medicine , 2015, Redox biology.

[78]  Siiri Latvala,et al.  Dry Generation of CeO2 Nanoparticles and Deposition onto a Co-Culture of A549 and THP-1 Cells in Air-Liquid Interface—Dosimetry Considerations and Comparison to Submerged Exposure , 2020, Nanomaterials.

[79]  B. Halliwell,et al.  Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean? , 2004, British journal of pharmacology.

[80]  A. Ghio,et al.  Biodegradability of para-aramid respirable-sized fiber-shaped particulates (RFP) in human lung cells. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[81]  V. Fessard,et al.  Genotoxicity of synthetic amorphous silica nanoparticles in rats following short‐term exposure, part 2: Intratracheal instillation and intravenous injection , 2015, Environmental and molecular mutagenesis.

[82]  Robert Landsiedel,et al.  Abiotic dissolution rates of 24 (nano)forms of 6 substances compared to macrophage-assisted dissolution and in vivo pulmonary clearance: Grouping by biodissolution and transformation , 2018, NanoImpact.

[83]  Marianne Geiser,et al.  Deposition and biokinetics of inhaled nanoparticles , 2010, Particle and Fibre Toxicology.

[84]  Changyou Gao,et al.  Toxicity of ZnO nanoparticles to macrophages due to cell uptake and intracellular release of zinc ions. , 2014, Journal of nanoscience and nanotechnology.

[85]  Christie M Sayes,et al.  A framework for grouping nanoparticles based on their measurable characteristics , 2013, International journal of nanomedicine.

[86]  Christie M. Sayes,et al.  Aerosol generation and characterization of multi-walled carbon nanotubes exposed to cells cultured at the air-liquid interface , 2015, Particle and Fibre Toxicology.

[87]  Robert Landsiedel,et al.  An in vitro alveolar macrophage assay for predicting the short-term inhalation toxicity of nanomaterials , 2016, Journal of Nanobiotechnology.

[88]  M. Viant,et al.  Multi-omics approaches confirm metal ions mediate the main toxicological pathways of metal-bearing nanoparticles in lung epithelial A549 cells , 2018 .

[89]  Tian Xia,et al.  NLRP3 inflammasome activation induced by engineered nanomaterials. , 2013, Small.

[90]  Verena Wilhelmi,et al.  Zinc Oxide Nanoparticles Induce Necrosis and Apoptosis in Macrophages in a p47phox- and Nrf2-Independent Manner , 2013, PloS one.

[91]  Reinhard Kreiling,et al.  A critical appraisal of existing concepts for the grouping of nanomaterials. , 2014, Regulatory toxicology and pharmacology : RTP.

[92]  Hedwig M Braakhuis,et al.  Grouping nanomaterials to predict their potential to induce pulmonary inflammation. , 2016, Toxicology and applied pharmacology.

[93]  Xiang Wang,et al.  Nanomaterial toxicity testing in the 21st century: use of a predictive toxicological approach and high-throughput screening. , 2013, Accounts of chemical research.

[94]  C. Egles,et al.  Predicting the in vivo pulmonary toxicity induced by acute exposure to poorly soluble nanomaterials by using advanced in vitro methods , 2018, Particle and Fibre Toxicology.

[95]  Fernando Rodrigues-Lima,et al.  Nanoparticles: molecular targets and cell signalling , 2011, Archives of Toxicology.

[96]  Margriet Vdz Park,et al.  Development of a systematic method to assess similarity between nanomaterials for human hazard evaluation purposes – lessons learnt , 2018, Nanotoxicology.

[97]  Matthew Boyles,et al.  A Method to Assess the Relevance of Nanomaterial Dissolution during Reactivity Testing , 2020, Materials.

[98]  Mark R. Miller,et al.  Differences in the toxicity of cerium dioxide nanomaterials after inhalation can be explained by lung deposition, animal species and nanoforms , 2018, Inhalation toxicology.

[99]  A. Zajícová,et al.  Molecular Responses in THP-1 Macrophage-Like Cells Exposed to Diverse Nanoparticles , 2019, Nanomaterials.

[100]  M. Feldstein,et al.  Pulmonary clearance and hilar lymph node content in rats after particle exposure. , 1978, Environmental research.

[101]  Mark D. Hoover,et al.  Characterization of phagolysosomal simulant fluid for study of beryllium aerosol particle dissolution. , 2005, Toxicology in vitro : an international journal published in association with BIBRA.

[102]  I. Lynch,et al.  Air–Liquid Interface Exposure of Lung Epithelial Cells to Low Doses of Nanoparticles to Assess Pulmonary Adverse Effects , 2020, Nanomaterials.

[103]  Read-Across Assessment Framework (RAAF) , 2017 .

[104]  W. MacNee,et al.  Progressive severe lung injury by zinc oxide nanoparticles; the role of Zn2+ dissolution inside lysosomes , 2011, Particle and Fibre Toxicology.

[105]  N. Chatterjee,et al.  Global metabolomics approach in in vitro and in vivo models reveals hepatic glutathione depletion induced by amorphous silica nanoparticles. , 2018, Chemico-biological interactions.

[106]  M. Gualtieri,et al.  In vitro acellular dissolution of mineral fibres: A comparative study , 2018, Scientific Reports.

[107]  B. Rihn,et al.  Cytotoxicity and global transcriptional responses induced by zinc oxide nanoparticles NM 110 in PMA-differentiated THP-1 cells. , 2019, Toxicology letters.

[108]  Detlef Ritter,et al.  Air–Liquid Interface In Vitro Models for Respiratory Toxicology Research: Consensus Workshop and Recommendations , 2018, Applied in vitro toxicology.

[109]  P. Borm,et al.  Nanoparticles in drug delivery and environmental exposure: same size, same risks? , 2006, Nanomedicine.

[110]  N. Konduru,et al.  Bioavailability, distribution and clearance of tracheally instilled, gavaged or injected cerium dioxide nanoparticles and ionic cerium , 2014 .

[111]  V. Shur,et al.  On the contribution of the phagocytosis and the solubilization to the iron oxide nanoparticles retention in and elimination from lungs under long-term inhalation exposure. , 2016, Toxicology.

[112]  A Worth,et al.  Grouping of nanomaterials to read-across hazard endpoints: a review , 2018, Nanotoxicology.

[113]  G. Hutchison,et al.  Nanoparticle interactions with zinc and iron: implications for toxicology and inflammation. , 2007, Toxicology and applied pharmacology.

[114]  Sophie Lanone,et al.  Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines , 2009, Particle and Fibre Toxicology.

[115]  David M. Brown,et al.  Proinflammatory Effects of Particles on Macrophages and Epithelial Cells , 2006 .